Results 281 to 290 of about 273,161 (350)

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma. [PDF]

J Clin Oncol
Neelapu SS, Chavez JC, Sehgal AR, Epperla N, Ulrickson ML, Bachy E, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Oluwole OO, Yakoub-Agha I, Khanal R, Rosenblatt JD, Wulff J, Shen RR, Zhang W, Poddar S, Miao H, Nikolajeva O, Jacobson CA.   +22 more
europepmc   +1 more source

Laryngeal non-Hodgkin lymphoma presenting as throat foreign body sensation: A case report. [PDF]

Medicine (Baltimore)
Liao H, He A, Yan F, He B.
europepmc   +1 more source

Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study.

JMIR Res Protoc
Du R, Zhang Y, Yang H, Du Y, Li J, Zhang B.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Blood and Marrow Transplant Handbook, 2021
Hematopoietic cell transplantation (HCT) is a key treatment modality in the management of advanced Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Autologous HCT (autoHCT) can be curative for relapsed or refractory HL and diffuse large B-cell lymphoma.
A. Chen
openaire   +2 more sources

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Journal of Clinical Oncology, 2014
Bruce D Cheson, Richard I Fisher, Sally F Barrington   +2 more
exaly   +2 more sources

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Nature, 2011
Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most common non-Hodgkin lymphomas (NHLs). Here we sequenced tumour and matched normal DNA from 13 DLBCL cases and one FL case to identify genes with mutations in B-cell NHL ...
Ryan D Morin, Andrew J Mungall, Richard D Corbett   +2 more
exaly   +2 more sources

PET/CT in Non-Hodgkin Lymphoma: An Update.

Seminars in nuclear medicine, 2022
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative disorders characterized by different clinical courses, varying from indolent to highly aggressive.
L. Zanoni, Davide Bezzi, C. Nanni, A. Paccagnella, A. Farina, A. Broccoli, B. Casadei, P. Zinzani, S. Fanti   +8 more
semanticscholar   +1 more source

Non-Hodgkin's lymphoma

European Journal of Cancer, 1998
To review the etiology, epidemiology, classification, diagnosis, staging, prognosis, treatment, and nursing implications of non-Hodgkin's lymphoma.Research studies, review articles, and book chapters pertaining to non-Hodgkin's lymphoma.Non-Hodgkins's lymphomas are a heterogeneous group of lympho-proliferative disorders, increasing in frequency, for ...
B A, Bilodeau, K L, Fessele
openaire   +4 more sources

Non-Hodgkin Lymphoma

The Lancet, 2017
Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10% of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar.
Zeppa P., Cozzolino I.
openaire   +4 more sources